Literature DB >> 10438267

The rising incidence of hepatocellular carcinoma.

J Kaczynski, A Odén.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10438267     DOI： 10.1056/NEJM199908053410613

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

1.  Starting Dose of Sorafenib for the Treatment of Hepatocellular Carcinoma: A Retrospective, Multi-Institutional Study.

Authors:  Kim A Reiss; Shun Yu; Ronac Mamtani; Rajni Mehta; Kathryn D'Addeo; E Paul Wileyto; Tamar H Taddei; David E Kaplan
Journal:  J Clin Oncol       Date:  2017-09-05       Impact factor: 44.544

2.  Expression of lysosome-associated protein transmembrane 4B-35 in cancer and its correlation with the differentiation status of hepatocellular carcinoma.

Authors:  Cong Peng; Rou-Li Zhou; Gen-Ze Shao; Jing-An Rui; Shao-Bin Wang; Ming Lin; Sha Zhang; Zi-Feng Gao
Journal:  World J Gastroenterol       Date:  2005-05-14       Impact factor: 5.742

3.  Magnitude of change in alpha-fetoprotein in response to transarterial chemoembolization predicts survival in patients undergoing liver transplantation for hepatocellular carcinoma.

Authors:  M Bhat; M Hassanain; E Simoneau; G N Tzimas; P Chaudhury; M Deschenes; D Valenti; P Ghali; P Wong; T Cabrera; J Barkun; J I Tchervenkov; P Metrakos
Journal:  Curr Oncol       Date:  2013-10       Impact factor: 3.677

Review 4.  Adverse events of sorafenib in hepatocellular carcinoma treatment.

Authors:  Yongsheng Pang; Aydin Eresen; Zigeng Zhang; Qiaoming Hou; Yining Wang; Vahid Yaghmai; Zhuoli Zhang
Journal:  Am J Cancer Res       Date:  2022-06-15       Impact factor: 5.942

5.  Sorafenib prescribed by gastroenterologists and hepatologists for hepatocellular carcinoma: A retrospective, multi-institutional cohort study.

Authors:  David E Kaplan; Rajni Mehta; Kathryn D'Addeo; Adriana Valderrama; Tamar H Taddei
Journal:  Medicine (Baltimore)       Date:  2018-01       Impact factor: 1.889
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.